Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Digestive Diseases and Sciences
|
February 28, 2025
Delays in Utilizing Biological Therapy Is a Global Reality and May Lead to Negative Outcomes in Patients with Inflammatory Bowel Disease
Anna H Owings, Sarah C Glover, Adam S Cheifetz, et al.
The American Journal of Gastroenterology
|
September 13, 2021
Response to Cheng et al
Julia J Liu, Anna H Owings, Brian Claggett, et al.
International Journal of Molecular Sciences
|
January 21, 2023
COVID-19 Plasma Extracellular Vesicles Increase the Density of Lipid Rafts in Human Small Airway Epithelial Cells
Sara Darwish, Lauren P Liu, Tanya O Robinson, et al.
BMC Urology
|
January 5, 2022
Urinary manifestations in African American and Caucasian inflammatory bowel disease patients: a retrospective cohort study
Jake Herbert, Emily Teeter, Landen Shane Burstiner, et al.
Immunity, Inflammation and Disease
|
July 8, 2025
Fatty Acids and Inflammatory Protein Biomarkers From Coronavirus Disease 2019 Patients
Niharika Bala, Alaa H Habib, Marianne Kozuch, et al.
The American Journal of the Medical Sciences
|
February 26, 2023
A focused retrospective study on differences in IBD characteristics between Black and White patients in the south
Landen Shane Burstiner, Anna H Owings, Collin Tacy, et al.
Frontiers in Allergy
|
February 6, 2026
MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemia
Michelle Galeas-Pena, Jonathan J Lyons, Dhana Llivichuzhca-Loja, et al.
Inflammatory Bowel Diseases
|
February 22, 2023
Black Inflammatory Bowel Disease Patients Have Lower Response to Antitumor Necrosis Factor Agents Compared With White Patients
Landen Shane Burstiner, Anna H Owings, Amor Royer, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 8, 2026
MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemia
Michelle Galeas-Pena, Jonathan J Lyons, Dhana Llivichuzhca-Loja, et al.
Digestive Diseases and Sciences
|
July 4, 2024
Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease
Alexander Abadir, Angela Troia, Hyder Said, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Digestive Diseases and Sciences
|
February 28, 2025
Delays in Utilizing Biological Therapy Is a Global Reality and May Lead to Negative Outcomes in Patients with Inflammatory Bowel Disease
Anna H Owings, Sarah C Glover, Adam S Cheifetz, et al.
The American Journal of Gastroenterology
|
September 13, 2021
Response to Cheng et al
Julia J Liu, Anna H Owings, Brian Claggett, et al.
International Journal of Molecular Sciences
|
January 21, 2023
COVID-19 Plasma Extracellular Vesicles Increase the Density of Lipid Rafts in Human Small Airway Epithelial Cells
Sara Darwish, Lauren P Liu, Tanya O Robinson, et al.
BMC Urology
|
January 5, 2022
Urinary manifestations in African American and Caucasian inflammatory bowel disease patients: a retrospective cohort study
Jake Herbert, Emily Teeter, Landen Shane Burstiner, et al.
Immunity, Inflammation and Disease
|
July 8, 2025
Fatty Acids and Inflammatory Protein Biomarkers From Coronavirus Disease 2019 Patients
Niharika Bala, Alaa H Habib, Marianne Kozuch, et al.
The American Journal of the Medical Sciences
|
February 26, 2023
A focused retrospective study on differences in IBD characteristics between Black and White patients in the south
Landen Shane Burstiner, Anna H Owings, Collin Tacy, et al.
Frontiers in Allergy
|
February 6, 2026
MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemia
Michelle Galeas-Pena, Jonathan J Lyons, Dhana Llivichuzhca-Loja, et al.
Inflammatory Bowel Diseases
|
February 22, 2023
Black Inflammatory Bowel Disease Patients Have Lower Response to Antitumor Necrosis Factor Agents Compared With White Patients
Landen Shane Burstiner, Anna H Owings, Amor Royer, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 8, 2026
MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemia
Michelle Galeas-Pena, Jonathan J Lyons, Dhana Llivichuzhca-Loja, et al.
Digestive Diseases and Sciences
|
July 4, 2024
Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease
Alexander Abadir, Angela Troia, Hyder Said, et al.
Page
of 2